HSBC Holdings’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,258
Closed -$645K 3064
2026
Q1
$645K Buy
19,258
+725
+4% +$24.3K ﹤0.01% 2093
2025
Q4
$644K Sell
18,533
-1,873
-9% -$59.7K ﹤0.01% 2180
2025
Q3
$560K Sell
20,406
-17,284
-46% -$418K ﹤0.01% 2045
2025
Q2
$804K Sell
37,690
-47,301
-56% -$908K ﹤0.01% 1905
2025
Q1
$1.36M Buy
84,991
+46,301
+120% +$986K ﹤0.01% 1611
2024
Q4
$980K Buy
38,690
+15,465
+67% +$438K ﹤0.01% 1814
2024
Q3
$732K Buy
23,225
+7,956
+52% +$302K ﹤0.01% 1831
2024
Q2
$528K Buy
15,269
+6,789
+80% +$269K ﹤0.01% 1943
2024
Q1
$372K Sell
8,480
-2,693
-24% -$116K ﹤0.01% 2278
2023
Q4
$403K Sell
11,173
-2,226
-17% -$66.4K ﹤0.01% 2146
2023
Q3
$359K Buy
+13,399
New +$340K ﹤0.01% 2123
2022
Q2
Sell
-11,787
Closed -$133K 3341
2022
Q1
$133K Buy
+11,787
New +$174K ﹤0.01% 3080
2019
Q4
Sell
-10,316
Closed -$93K 3108
2019
Q3
$93K Buy
+10,316
New +$78.7K ﹤0.01% 2985

Other funds holding IDYA

HSBC Holdings's IDYA Position: Q2 2026 in Review

HSBC Holdings sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 19,258 shares — an estimated $645K sold.

HSBC Holdings first reported a position in IDYA in Q3 2019 and held it in 13 quarters. The position peaked at $1.36M in Q1 2025. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • HSBC Holdings reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 19,258 IDEAYA Biosciences shares in Q2 2026, an estimated $645K.
  • HSBC Holdings first reported a position in IDEAYA Biosciences in Q3 2019 and held it in 13 quarters.
  • HSBC Holdings's IDEAYA Biosciences position peaked at $1.36M in Q1 2025.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.